EP-2104R: A Fibrin-Specific Gadolinium-Based MRI Contrast Agent for Detection of Thrombus-Reference-Cited by-同舟云学术

EP-2104R: A Fibrin-Specific Gadolinium-Based MRI Contrast Agent for Detection of Thrombus

Published:2008-04-08 Issue:18 Volume:130 Page:6025-6039
ISSN:0002-7863
Container-title:Journal of the American Chemical Society
language:en
Short-container-title:J. Am. Chem. Soc.

Author:

Overoye-Chan Kirsten¹,Koerner Steffi¹,Looby Richard J.¹,Kolodziej Andrew F.¹,Zech Stephan G.¹,Deng Qing¹,Chasse Jaclyn M.¹,McMurry Thomas J.¹,Caravan Peter¹

Affiliation:

1. EPIX Pharmaceuticals, 4 Maguire Road, Lexington, Massachusetts 02421, and Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown, Massachusetts 02429

Publisher

American Chemical Society (ACS)

Subject

Colloid and Surface Chemistry,Biochemistry,General Chemistry,Catalysis

Link

https://pubs.acs.org/doi/pdf/10.1021/ja800834y

Reference68 articles.

1. What Does It Take to Make the Perfect Clot?

2. Biological Evaluation of Thrombus Imaging Agents Utilizing Water Soluble Phosphines and Tricine as Coligands When Used To Label a Hydrazinonicotinamide-Modified Cyclic Glycoprotein IIb/IIIa Receptor Antagonist with 99mTc

3. The safety and pharmacokinetics in adult subjects of an intravenously administered 99mTc-labeled 17 amino acid peptide (CYT-379)

4. Preparation and Characterization of [99TcO] Apcitide: A Technetium Labeled Peptide

Cited by 196 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proteomic evidence for amyloidogenic cross-seeding in fibrinaloid microclots;2024-07-17

2. MRI-based microthrombi detection in stroke with polydopamine iron oxide;Nature Communications;2024-06-13

3. Peptide-based targeting: Novel concept for thrombosis diagnosis and treatment;Journal of Drug Delivery Science and Technology;2024-05

4. Molecular Imaging of Fibrosis in Benign Diseases: An Overview of the State of the Art;Pharmaceuticals;2024-02-26

5. Peptide-Conjugated MRI Probe Targeted to Netrin-1, a Novel Metastatic Breast Cancer Biomarker;Bioconjugate Chemistry;2024-02-10